At the time of writing, Healthpeak Properties Inc. [PEAK] stock is trading at $17.10, up 2.09%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PEAK shares have gain 2.83% over the last week, with a monthly amount drifted -7.57%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 1, March 2024, Healthpeak Properties to Present at the Citi 2024 Global Property CEO Conference and Publishes Updated Investor Presentation. In a post published today on Yahoo Finance, Healthpeak Properties, Inc. (NYSE: PEAK), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that Scott Brinker, its President and Chief Executive Officer, is scheduled to present at the Citi 2024 Global Property CEO Conference.
From an analyst’s perspective:
Healthpeak Properties Inc. [NYSE: PEAK] stock has seen the most recent analyst activity on February 12, 2024, when Exane BNP Paribas upgraded its rating to a Neutral but kept the price target unchanged to $19 for it. Previously, Deutsche Bank started tracking the stock with Hold rating on January 30, 2024, and set its price target to $21. On January 12, 2024, upgrade upgraded it’s rating to Sector Outperform and revised its price target to $23 on the stock. BofA Securities downgraded its rating to a Underperform but stick to its price target of $17.50 on November 13, 2023. Exane BNP Paribas initiated its recommendation with a Underperform and recommended $18 as its price target on October 11, 2023. Wedbush started tracking with a Neutral rating for this stock on October 03, 2023, and assigned it a price target of $19. In a note dated April 24, 2023, Mizuho upgraded an Buy rating on this stock and revised its target price from $29 to $25.
For the past year, the stock price of Healthpeak Properties Inc. fluctuated between $15.24 and $24.46. Currently, Wall Street analysts expect the stock to reach $33 within the next 12 months. Healthpeak Properties Inc. [NYSE: PEAK] shares were valued at $17.10 at the most recent close of the market. An investor can expect a potential return of 92.98% based on the average PEAK price forecast.
Analyzing the PEAK fundamentals
According to Healthpeak Properties Inc. [NYSE:PEAK], the company’s sales were 2.18B for trailing twelve months, which represents an 5.56% jump. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.05 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.68 points at the first support level, and at 16.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.33, and for the 2nd resistance point, it is at 17.56.
Healthpeak Properties Inc. [PEAK] reported earnings per share of $0.13 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.1/share, meaning a difference of $0.03 and a surprise factor of 30.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.12 per share as compared to estimates of $0.08 per share, a difference of $0.04 representing a surprise of 50.00%.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 4.29, the price to book ratio is 1.47 and price to earnings (TTM) ratio is 30.76.
Transactions by insiders
Recent insider trading involved Lewis Sara Grootwassink, Director, that happened on Mar 15 when 4000.0 shares were purchased. COO, Klaritch Thomas completed a deal on Mar 07 to buy 1517.0 shares.
